Avidity Biosciences
RNA
#2567
Rank
ยฃ4.37 B
Marketcap
ยฃ36.67
Share price
-0.83%
Change (1 day)
682.59%
Change (1 year)

Avidity Biosciences (RNA) - Cash on Hand

Cash on Hand as of June 2024 : ยฃ1.01 Billion

According to Avidity Biosciences's latest financial reports the company has ยฃ1.01 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Avidity Biosciences - Cash on Hand chart (from 2019 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31ยฃ0.46 B-7.43%
2022-12-31ยฃ0.50 B68.03%
2021-12-31ยฃ0.30 B24.8%
2020-12-31ยฃ0.24 B233.78%
2019-12-31ยฃ72.12 M2862.87%
2018-12-31ยฃ2.43 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
ยฃ0.79 B-21.99%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ7.34 M-99.28%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.94 B-7.75%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.34 B-65.95%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.23 B-76.53%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ7.80 B 666.10%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ3.37 B 230.91%๐Ÿ‡ฌ๐Ÿ‡ง UK